Pharmacokinetics of heterologous and homologous immunoglobulin G, F(ab')2 and Fab after intravenous administration in the rat

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 3, 1997, Pages 277-281

  Bazin Redureau, Martine I ^a,b   Renard, Catherine B ^a   Scherrmann, Jean Michel G ^a  

^a HÔPITAL FERNAND WIDAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; IODINE 125;

ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN RESIDENCE TIME; MOLECULAR WEIGHT; NONHUMAN; RAT; SPECIES;

EID: 0030900254     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06795.x     Document Type: Article

References (27)

1. Andrew, S. M., Titus, J. A. (1991) Antibody detection and preparation. In: Colligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M., Strober, W. (eds) Current Protocols in Immunology. Green Publishing Associates and Wiley-Interscience, New York, pp 2.8.1-2.8.10
2. Arizono, H., Ishii, S., Nagao, T., Kudo, S., Sasaki, S., Kondo, S., Kiyoki, M. (1994) Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Arzneim. Forsch. 44: 890-898
3. Azuma, J., Kurimoto, T., Tsujii, S. J. (1991) Phase I study on human monoclonal antibody against cytomegalovirus-pharmacokinetics and immunogenicity. Immunotherapy 10: 278-85
4. Baud, F. J., Sabouraud, A., Vicaut, E., Taboulet, P., Lang, J., Bismuth, C., Rouzioux, J. M., Scherrmann, J. M. (1995) Treatment of severe colchicine overdose with colchicine-specific Fab fragments. N. Engl. J. Med. 332: 642-645
5. Brown, B. A., Davis, G. L., Muller, J. S., Simon, P., Ho, M. K., Shaw, P. S., Stone, B. A., Sands, H., Moore, G. P. (1987) Tumor-specific genetically engineered murine/human chimeric monoclonal antibody. Cancer Res. 47: 3577-3583
6. 2 fragments in ovarian carcinoma patients. Cancer Res. 53: 5413-5418
7. 2, and Fab′ in mice. Cancer Res. 46: 3969-3978
8. Demignot, S., Pimm, M. V., Baldwin, R. W. (1990) Comparison of biodistribution of 791T/36 monoclonal antibody. Cancer Res. 50: 2936-2942
9. Fraker, P. J., Speck, J. C. (1978) Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80: 849-857
10. Henderson, L. A., Baynes, J. W., Thorpe, S. R. (1982) Identification of the sites of IgG catabolism in the rat. Arch. Biochem. Biophys. 215: 1-11
11. Knapp, M. J., Colburn, P. A. (1990) Clinical uses of intravenous immune globulin. Clin. Pharm. 9: 509-529
12. 2 fragments for radioimmunoimaging of human colon cancer in nude mice. Nucl. Med. Biol. 20: 243-248
13. 4. Nature (London) 277: 680-685
14. McClurkan, M. B., Valentine, J. L., Arnold, L., Owens, S. M. (1993) Disposition of a monoclonal anti-phencyclidine Fab fragments of immunoglobulin G in rats. J. Pharmacol. Exp. Ther. 266: 1439-1445
15. Mehvar, R., Shepard, T. L. (1992) Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats. J. Pharm. Sci. 81: 908-912
16. Moran, R. J., Struthers, A. D., Hewick, D. S. (1994) Digoxin-specific Fab fragments impair renal function in the rat. J. Pharm. Pharmacol. 46: 854-856
17. 125I] venoglobulin-IH in rats and rabbits. Iyakuhin Kenkyu. 20: 1220-1243
18. Pentel, P. R., Keyler, D. E., Gilbertson, D. G., Ruth, G., Pond, S. M. (1988) Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats. Drug Metab. Dispos. 16: 141-145
19. Peppard, J. V., Orlans, E. (1980) The biological half-lives of four rat immunoglobulin isotypes. Immunology 40: 683-686
20. Smith, T. W., Lloyd, B. L., Spicer, N., Haber, E. (1979) Immunogenecity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon. Clin. Exp. Immunol. 36: 384-396
21. Timsina, M. P., Hewick, D. S. (1992) Digoxin-specific Fab fragments impair renal function in the rabbit. J. Pharm. Pharmacol. 44: 796-800
22. Triguero, D., Buciak, J. L., Pardridge, W. M. (1991) Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate. J. Pharmacol. Exp. Ther. 258: 186-192
23. Wahyono, D., Piechaczyk, M., Mourton, C., Bastide, J. M., Pau, B. (1990) Novel anti-digoxin monoclonal antibodies with different binding specificities for digoxin metabolites and other glycosides. Hybridoma. 9: 619-629
24. H2 domains. Mol. Immunol. 29: 213-220
25. Weigle, X. O. (1957) Characterization of the asialoglycoprotein receptor on isolated rat hepatocytes. Proc. Soc. Exp. Biol. Med. 94: 306-309
26. Yokota, T., Milenic, D. E., Whitlow, M., Wood, J. F., Hubert, S. L., Schlom, J. (1993) Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. Cancer Res. 53: 3776-3783
27. 2 fragments in a xenograft model. Cancer Lett. 76: 31-44